Check out our latest published research and learn more about what grant funding we have received
Latest publications
Improving Regulatory Science in Neonates for Improved Drug Development
- Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale
- The neonatal adverse event severity scale: current status, a stakeholders’ assessment, and future perspectives
- Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
Pharmacovigilance
Pharmacoepidemiology
Developmental Pharmacology
- Rules of Thumb for Estimating Drug Levels in Breast Milk: How Well Do They Work?
- Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life
- Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
- Could Postnatal Age-Related Uridine Diphosphate Glucuronic Acid Be a Rate-Limiting Factor in the Metabolism of Morphine During the First Week of Life?
- The Relationship of Indomethacin Exposure With Efficacy and Renal Toxicity Outcomes for Preterm Infants in the Neonatal Intensive Care Unit
Pharmacogenetics and personalized medicine
- Opioid-Related Pharmacogenomic Variants in a Retrospective Cohort of High-Risk Hospitalized Infants
- Optimizing proton-pump inhibitor therapy in paediatric eosinophilic esophagitis through CYP2C19 pharmacogenetic testing
- Pediatric pharmacogenetics in the community: a future where all children benefit from personalized therapeutics
